Efficacy of recombinant activated factor VII vs. activated prothrombin complex concentrate for patients suffering from haemophilia complicated with inhibitors: a Bayesian meta-regression-Reference-Cited by-同舟云学术

Efficacy of recombinant activated factor VII vs. activated prothrombin complex concentrate for patients suffering from haemophilia complicated with inhibitors: a Bayesian meta-regression

Published:2009-03 Issue:2 Volume:15 Page:420-436
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

TREUR M. J.,MCCRACKEN F.,HEEG B.,JOSHI A. V.,BOTTEMAN M. F.,DE CHARRO F.,VAN HOUT B.

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2008.01956.x/fullpdf

Reference67 articles.

1. Effects of hemophilia on articulations of children and adults;Rodriguez-Merchan;Clin Orthop Relat Res,1996

2. Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation;Hay;Thromb Haemost,1998

3. Factor IX inhibitors in haemophilia B patients: their incidence and prospects for development with high purity factor IX products;Briet;Blood Coagul Fibrinolysis,1991

4. A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study;Astermark;Blood,2007

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The More Recent History of Hemophilia Treatment;Seminars in Thrombosis and Hemostasis;2022-09-15

2. Prophylaxis is the new standard of care in patients with haemophilia;South African Medical Journal;2022-06-01

3. Bleeding in patients with hemophilia who have inhibitors: Modeling US medical system utilization and cost avoidance between recombinant factor VIIa products with different clinical dosing requirements;Journal of Managed Care & Specialty Pharmacy;2022-05

4. Thromboelastography in pre-surgery monitoring in Hemophilia A with high inhibitor titer: case report and literature review;Revista Romana de Medicina de Laborator;2020-04-01

5. Cost-Effectiveness of rFVIIa versus pd-aPCC in the Management of Mild to Moderate Bleeds in Pediatric Patients with Hemophilia A with Inhibitors in Mexico;Value in Health Regional Issues;2018-12